DOUGLAS G BAILEY
CIK 1246268 · Executive Chairman · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.81M
Companies
2
Total Filings
66
Lifetime Open-Market Net
-$1.56M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FTEK | Director | 2,093,561 | $1.34 | $2.81M | -$1.98M | 61 | 2026-06-05 |
| ENDOCYTE INC (ECYT) Delisted | Director | 475,363 | — | — | $420.0K | 5 | 2012-06-04 |
Recent Filings · Page 2 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-02-24 | FTEK | Grant (A) | +12,000 | $0 | EDGAR |
| 2016-03-22 | FTEK | Grant (A) | +12,000 | $0 | EDGAR |
| 2016-03-03 | FTEK | Grant (A) | +14,400 | $0 | EDGAR |
| 2016-01-04 | FTEK | Buy (P) | +15,000 | $27.8K | EDGAR |
| 2015-03-30 | FTEK | Grant (A) | +21,000 | $0 | EDGAR |
| 2015-03-10 | FTEK | Grant (A) | +21,600 | $0 | EDGAR |
| 2014-12-30 | FTEK | Buy (P) | +30,000 | $110.7K | EDGAR |
| 2014-10-22 | FTEK | Other (J) | — | $0 | EDGAR |
| 2014-10-22 | FTEK | Buy (P) | +6,800 | $28.7K | EDGAR |
| 2014-09-25 | FTEK | Buy (P) | +6,800 | $28.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.